Here are relevant reports on : artificial-intelligence-personalized-medicine-market
-
Pharmacogenomics Market by Product & Service (Kits & Reagents), Technology (Sequencing, PCR, Microarray), Application (Drug Discovery, Clinical Research, Personalized Medicine), Disease Area (Cancer, Neurological, Cardiovascular) - Global Forecast to 2028
The global pharmacogenomics market, valued at US$3.3 billion in 2022, stood at US$3.5 billion in 2023 and is projected to advance at a resilient CAGR of 10.6% from 2023 to 2028, culminating in a forecasted valuation of US$5.8 billion by the end of the period. The increasing focus on the translational approach to optimize drug development processes, increasing collaborations and partnerships between key players and research institutes, and rising incidence of cancer are the major driving factors of the pharmacogenomics market.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Europe Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, mRNA), Application (Diagnostics, Personalized Medicine), End User (CROs) - Forecast to 2030
The Europe nucleic acid isolation and purification market, valued at USD1.52 billion in 2024, stood at USD1.61 billion in 2025 and is projected to advance at a resilient CAGR of 8.4% from 2025 to 2030, culminating in a forecasted valuation of USD2.41 billion by the end of the period. The growth of the Europe nucleic acid isolation and purification market is strongly linked to the region’s high volume of molecular tests and the steady adoption of PCR- and NGS-based workflows.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Human Organoids Market by Product (Liver, Kidney, Pancreatic Models (2D, 3D)), Disease Area (Oncology, GI, Neurological Disorders), Application (Drug Toxicity, Personalized Medicine), End User (Pharma & Biotech Companies, CROs) - Global Forecast to 2029
The global human organoids market, valued at US$1.07 billion in 2023, stood at US$1.19 billion in 2024 and is projected to advance at a resilient CAGR of 14.4% from 2024 to 2029, culminating in a forecasted valuation of US$2.33 billion by the end of the period. The main factor driving this market is the rising demand for organoids in drug testing, as they provide more reliable results than conventional 2D cell cultures.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Mice Model Market by Model Type (Inbred, Outbred, Hybrid), Service (Breeding, Rederivation), Application (Personalized Medicine), Technology (Microinjection, CRISPR/Cas9), Therapeutic Area (Oncology, Neurology), End User (CROs) - Global Forecast to 2030
The global mice model market, valued at US$1.53 billion in 2024, stood at US$1.70 billion in 2025 and is projected to advance at a resilient CAGR of 10.0% from 2025 to 2030, culminating in a forecasted valuation of US$2.74 billion by the end of the period. The growth of this market is driven by several factors, such as rising adoption of mice models in preclinical studies due to genetic & physiological versatility; the increasing demand for mouse clinical trials; the rising demand for personalized medicine in oncology; and advancements in genetic engineering.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
North America Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA), Application (Diagnostics, Personalized Medicine), End User (CROs) - Forecast to 2030
The North America Nucleic Acid Isolation and Purification Market, valued at USD 2.80 billion in 2024, stood at USD 2.98 billion in 2025 and is projected to advance at a resilient CAGR of 9.3% from 2025 to 2030, culminating in a forecasted valuation of USD 4.64 billion by the end of the period. The growth of the North America nucleic acid isolation and purification market is largely dependent on the region's substantial number of molecular tests and quick acceptance of NGS-based workflows.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Digital Twins in Healthcare Market By Component (Software, Services), Application (Personalized Medicine, Drug Discovery, Medical Education, Workflow Optimization), End User (Providers, Research & Academia, Payers), and Region - Global Forecast to 2031
The global digital twins in healthcare market is projected to reach USD 101.19 billion by 2031, growing at a CAGR of 68.4% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence (AI) Market by Offering [Hardware (AI Chips, Memory, Storage), Software, Services], Technology (ML, NLP, Generative AI, Neurosymbolic AI), Business Function (Operations & Supply Chain, Sales & Marketing) - Global Forecast to 2033
The Artificial intelligence (AI) market was estimated to be worth USD 601.93 billion in 2026 and is projected to reach USD 3,638.08 billion by 2033, at a CAGR of 29.3%. The major players in the artificial intelligence market include NVIDIA (US), Microsoft (US), Alphabet (US), Amazon Web Services (US), OpenAI (US), Meta (US), IBM (US), Anthropic (US), Cohere (Canada), Mistral AI (France), and Anyscale (US), among others.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
South Korea Artificial Intelligence in Manufacturing Market by Processor (MPUS, GPUs, FPGA, ASICs), Software (On-premises, Cloud), Technology (Machine Learning, NLP, Context-aware Computing, Computer Vision, Generative Al), Application - Forecast to 2030
The South Korea artificial intelligence in manufacturing market is projected to reach USD 5.98 billion by 2030 from USD 1.15 billion in 2025; it is expected to grow at a CAGR of 39.0% from 2026 to 2030. The key players include NVIDIA Corporation (US), IBM (US), Siemens (Germany), ABB (Switzerland), Honeywell International Inc. (US), GE Vernova (US), among others.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Germany Artificial Intelligence in Manufacturing Market by Processor (MPUS, GPUs, FPGA, ASICs), Software (On-premises, Cloud), Technology (Machine Learning, NLP, Context-aware Computing, Computer Vision, Generative Al), Application - Forecast to 2030
The Germany artificial intelligence in manufacturing market is projected to grow from USD 2.14 billion in 2026 and to reach USD 10.50 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 35.8% during the forecast period. Key companies providing innovative, data-driven solutions in this market include Siemens (Germany), ABB (Switzerland), and IBM (US).
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence in Tourism Market by Solution (Virtual Assistant & Chatbots, Pricing & Revenue Management, Booking Management System), End Users (Maritime Travel, Aviation, Cruise Line Operators, Resorts & Theme Parks) - Global Forecast to 2030
The AI in tourism market is projected to reach USD 13.38 billion by 2030 at a Compound Annual Growth Rate (CAGR) of 28.7% during the forecast period. The major vendors covered in the AI in tourism market are Snowflake (US), IBM (US), NVIDIA (US), Microsoft (US), AWS (US), Salesforce (US), Huawei (China), Appier (Taiwan), Sabre Corporation (US), SAS Institute (US), [24]7.ai (US), Virtusa Corporation (US), Travelport (UK), Amadeus (Spain), Devon Software (Poland) , Artisoft (US), Jio Haptik Technologies Limited (India), SHR Group (US), Duve (US), Nescient (US), Persado (US), Canary Technologies (US), Mize (US), FLYR (US), Geovana (US), Layla AI (Germany). These players have adopted various growth strategies, such as partnerships, agreements and collaborations, new product launches, enhancements, and acquisitions to expand their footprint in the AI in tourism market.
- Published: January 2025
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
